Novocure Ltd reports results for the quarter ended in September - Earnings Summary

NovoCure

26/10/2023 14:32

* Novocure Ltd  NVCR.OQ  reported a quarterly adjusted loss
of 46
cents​​ per share for the quarter ended in September. The mean
expectation of seven analysts for the quarter was for a loss
of 52 cents per share.
    * Revenue fell 2.8% to $127.32 million from a year ago;
analysts
expected $128.76 million. 
    * Novocure Ltd's reported EPS for the quarter was a loss
of 46
cents​.
    * The mean earnings estimate of analysts had risen by
about 2.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Novocure Ltd shares had fallen by 12.8% this quarter and
lost 80.8% so far this year.
    * The company reported a quarterly loss of $49.49 million.
    * Wall Street's median 12-month price target for Novocure
Ltd is
$35.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
October 26 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.52          -0.46          Beat
 Jun. 30 2023      -0.50          -0.54          Missed
 Mar. 31 2023      -0.32          -0.50          Missed
 Dec. 31 2022      -0.30          -0.36          Missed